Adage Capital Partners’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.6M | Buy |
4,589,000
+1,589,000
| +53% | +$10.9M | 0.05% | 335 |
|
|
2025
Q1 | $8.64M | Hold |
3,000,000
| – | – | 0.02% | 614 |
|
|
2024
Q4 | $14.1M | Buy |
3,000,000
+1,000,000
| +50% | +$4.7M | 0.02% | 525 |
|
|
2024
Q3 | $7.14M | Buy |
2,000,000
+1,700,000
| +567% | +$6.07M | 0.01% | 673 |
|
|
2024
Q2 | $1.86M | Sell |
300,000
-806,422
| -73% | -$5M | ﹤0.01% | 784 |
|
|
2024
Q1 | $10.4M | Sell |
1,106,422
-400,000
| -27% | -$3.78M | 0.02% | 588 |
|
|
2023
Q4 | $10.2M | Sell |
1,506,422
-900,000
| -37% | -$6.08M | 0.02% | 588 |
|
|
2023
Q3 | $10.7M | Buy |
2,406,422
+100,000
| +4% | +$444K | 0.02% | 547 |
|
|
2023
Q2 | $7.61M | Buy |
2,306,422
+500,000
| +28% | +$1.65M | 0.02% | 616 |
|
|
2023
Q1 | $5.15M | Buy |
1,806,422
+686,422
| +61% | +$1.96M | 0.01% | 705 |
|
|
2022
Q4 | $8.15M | Sell |
1,120,000
-200,000
| -15% | -$1.46M | 0.02% | 685 |
|
|
2022
Q3 | $10.7M | Buy |
1,320,000
+1,050,000
| +389% | +$8.49M | 0.03% | 619 |
|
|
2022
Q2 | $1.32M | Sell |
270,000
-1,680,000
| -86% | -$8.23M | ﹤0.01% | 909 |
|
|
2022
Q1 | $46.1M | Buy |
1,950,000
+230,000
| +13% | +$5.44M | 0.09% | 233 |
|
|
2021
Q4 | $30.4M | Buy |
1,720,000
+540,000
| +46% | +$9.55M | 0.05% | 343 |
|
|
2021
Q3 | $33.3M | Buy |
+1,180,000
| New | +$33.3M | 0.07% | 302 |
|